Related Experiment Video
Updated: Jun 12, 2026
12:25
Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
Botulinum toxin and pregnancy-a cautionary tale
1Tennent Institute of Ophthalmology, Glasgow, UK. jamesly@doctors.org.uk
Strabismus
|June 5, 2010
Summary
Botulinum toxin injections for squint treatment appear safe during pregnancy. A case study and literature review found no adverse effects on mothers or babies from this common eye muscle treatment.
Area of Science:
- Ophthalmology
- Neurology
- Reproductive Medicine
Background:
- Botulinum toxin type A is a widely used treatment for strabismus, including convergent squint.
- Safety data regarding botulinum toxin use during pregnancy is limited.
- Assessing the safety of medical treatments during gestation is crucial for maternal and fetal well-being.
Observation:
- A 17-year-old female received botulinum toxin injections for a left convergent squint.
- She discovered she was pregnant three days after her second injection.
- The pregnancy and delivery were uncomplicated, with no adverse effects noted for mother or infant.
Findings:
- A review of existing literature suggests botulinum toxin is relatively safe for use during pregnancy.
- Studies indicate that up to 300 units of botulinum toxin administered at various gestational stages have not resulted in adverse outcomes.
- This case supports the existing literature, indicating no negative impact from botulinum toxin treatment during pregnancy.
Implications:
- Botulinum toxin treatment for conditions like squint may be considered a relatively safe option for pregnant individuals.
- Further research could solidify the safety profile of botulinum toxin across different trimesters and dosages.
- This information can help guide clinical decisions and alleviate patient concerns regarding treatment during pregnancy.
More Related Videos
Related Concept Videos
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:29Tetanus
Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...